Peripheral Artery Disease Clinical Trial
Official title:
Effects of Pulse Varieties on Blood Vessel Function in Individuals With Peripheral Artery Disease (PAD)
Consumption of a diet containing pulse crops provides flavonoid compounds that will improve vascular function and glycemic control in individuals with Peripheral Artery Disease.
This is a single site, randomized, controlled, food intervention study designed to explore
the effects of pulse types and varieties on blood vessel function in individuals with
Peripheral Artery Disease.
Phase One(Acute): To identify relative potency of pulse types (beans,peas, lentils,and
chickpeas) for vascular activity in healthy participants and participants with Peripheral
Artery Disease. Healthy participants (10) and participants with Peripheral Artery Disease
(10) will be asked to consume (in random order) one test food per in-person visit over 5
visits scheduled a minimum of 6 days apart. Vascular responsiveness will be monitored
non-invasively by peripheral arterial tonometry before consumption of the test food and 2
hours post food consumption. Blood samples will be collected at the same time intervals for
analyses, of vascular, inflammatory, and metabolic markers as well as flavonoids present in
the pulses.
Phase Two(Chronic): Chronic 8-week study using mixed beans (pinto, kidney, black, and navy)
to determine improvements in vascular function, cardiovascular risk factors, and glycemic
control in participants with Peripheral Artery Disease (N=75, 25/group). Participants will
be randomly assigned to one of the following three groups: i) foods containing 0.6 cup mixed
beans/day consumed 5 days per week (total amount is 3 cups mixed beans per week); or, ii)
foods containing 0.3 cup mixed beans/day for 5 days per week); or, iii) pulse-free foods
(control) consumed 5 days/week. A total of 3 in-person visits for screening, baseline and
final will be required during the 8-week study schedule. Assessments of vascular function,
cognitive function, food dietary intake and preferences, flavonoid levels and cardiovascular
risk markers in blood and urine, glycemic control, and anthropometrics will be completed at
baseline and at 8 weeks.
Phase Three(Follow-Up: An 8-week follow-up assessment with a subset of participants
(n=10/group, 3 groups) with Peripheral Artery Disease will be done at 2, 4, and at 8 weeks.
Assessments of vascular function, cognitive function, food dietary intake, flavonoid levels
and cardiovascular risk markers in blood and urine, glycemic control, and anthropometrics
will be completed. These assessments will enable us to determine the length of time the
benefits of the pulse consumption are retained.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT05712395 -
The Effects of a Novel, Non-ischemic and Pain-free Exercise Intervention in Peripheral Artery Disease
|
N/A | |
| Active, not recruiting |
NCT04534257 -
Prospective Registry to Investigate the Safety and Efficacy of the Treatment With the Selution Sirolimus Drug Coated Balloon in TASC C and D Atheroma-occlusive Infra-Inguinal Disease in Patients With Chronic Limb Threatening Ischemia From Singapore
|
N/A | |
| Recruiting |
NCT04511234 -
Sirolimus Coated Balloon Versus Standard Balloon for SFA and Popliteal Artery Disease
|
N/A | |
| Recruiting |
NCT03506633 -
Impacts of Mitochondrial-targeted Antioxidant on Peripheral Artery Disease Patients
|
N/A | |
| Active, not recruiting |
NCT03506646 -
Dietary Nitrate Supplementation and Thermoregulation
|
N/A | |
| Completed |
NCT02554266 -
Registry Investigating the Clinical Use and Safety of the Lutonix Drug Coated Balloon for Treatment of BTK Arteries
|
||
| Completed |
NCT03921905 -
Peripheral Artery Disease in Patients With Stable Coronary Artery Disease in General Practice: Prevalence, Management and Clinical Outcomes.
|
||
| Not yet recruiting |
NCT06369350 -
Vitamin B6 on Exercise Pressor Reflex on Leg Ischemia-reperfusion
|
Early Phase 1 | |
| Recruiting |
NCT04545268 -
Prehabilitation for Cardiac Surgery in Patients With Reduced Exercise Tolerance
|
N/A | |
| Recruiting |
NCT02389023 -
Comparison of Prevena Negative Pressure Incision Management System vs. Standard Dressing After Vascular Surgery
|
N/A | |
| Completed |
NCT02539940 -
Elutax-SV Drug-eluting Balloons for Below-the-knee Treatment
|
||
| Completed |
NCT02563535 -
Evaluation of the Use of ACOTEC Drug-Eluting Balloon Litos ® in Below-The-Knee Arteries to Treat Critical Limb Ischemia
|
Phase 4 | |
| Completed |
NCT02542267 -
In-Stent Restenosis Post-Approval Study
|
N/A | |
| Completed |
NCT02522884 -
Tack Optimized Balloon Angioplasty Study of the Tack Endovascular Systemâ„¢ in Femoropoliteal Arteries
|
N/A | |
| Completed |
NCT02228564 -
BARD® Study of LIFESTREAMâ„¢ Balloon Expandable Covered Stent Treating Iliac Arterial Occlusive Disease
|
N/A | |
| Completed |
NCT02262949 -
A Prospective Study of the Bard® LifeStent® Solo Vascular Stent System
|
N/A | |
| Completed |
NCT02145065 -
First-in-man Evaluation of a Novel, Microcrystalline Paclitaxel Coated Balloon for Treatment of Femoropopliteal Artery Disease (PAX-r)
|
N/A | |
| Completed |
NCT01743872 -
Optical Imaging Measurement of Intravascular Solution Efficacy Trial
|
N/A | |
| Recruiting |
NCT01424020 -
Walking Estimated Limitation Calculated by History - Study 2
|
Phase 4 | |
| Active, not recruiting |
NCT01597453 -
NOR-SYS: The Norwegian Stroke in the Young Study
|
N/A |